Medical

  Baylor College of Medicine researchers are fighting cancer with a different approach. Instead of blocking messenger molecules, they accelerate their destruction. Their results, published in the Proceedings of the National Academy of Sciences, have the potential for improving cancer treatment.

Fujitsu Laboratories announced that it has developed a portable breath sensor that can extract and quickly measure the concentration of only specified gas components, such as ammonia, that are included at low concentrations in people's breath and are suggested to be correlated with lifestyle diseases. This sensor makes it easy to identify molecules that previously could only be identified using large analysis instruments.

MU and STMicroelectronics have announced that MU’s US-304 portable ultrasound imager, powered by ST’s STHV800pulser, is aiming to increase the quality of point-of-care medical diagnostics in remote rural areas of Africa. MU’s device has been developed for the 'Doctor Car' mobile-clinic project to provide medical care in remote rural areas of Africa.

Scientists at the California NanoSystems Institute at UCLA have developed a new technique for identifying cancer cells in blood samples faster and more accurately than the current standard methods. In one common approach to testing for cancer, doctors add biochemicals to blood samples. Those biochemicals attach biological "labels" to the cancer cells, and those labels enable instruments to detect and identify them.

Mapping blood flow in the brain of athletes using an advanced form of ultrasound may make it easier to more accurately recognise concussions, according to a study that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, 15th to 21st April, 2016. "There is growing evidence that concussions can change the blood flow in the brain," said study author Robert Hamilton, PhD, co-founder of Neural Analytics i...

  Researchers at McGill University in Montreal have recently developed a portable, paper-based electrochemical platform with multiplexing and telemedicine capabilities that may enable low-cost, point-of-care diagnosis of HIV and HCV co-infections within serum samples.

Designed for industry standard 0.550x1.125 mounting hole, the C1005B-Series is a switch and a circuit protector in one small, compact package. This combination device eliminates the need for both a switch and thermal circuit protector on customer panels. By using only this multipurpose product, wiring and assembly costs are greatly reduced, while at the same time saving valuable panel real estate. 

  A collaborative research team has found humanoid robotics and computer avatars could help rehabilitate people suffering from social disorders such as schizophrenia or social phobia. It is thanks to the theory of similarity, which suggests that it is easier to interact socially with someone who looks, behaves or moves like us.

Researchers have developed a light-activated tool to show how drugs need to be adapted to combat type 2 diabetes. The study, published in Angewandte Chemie, provides insight into the signalling process of receptors in cells. The team behind the research believe their findings could pave the way for the next-gen of anti-diabetic drugs that are activated by the presence of either blue or ultra-violet light.

  The recent epidemic of Zika virus infections in South and Latin America has raised serious concerns on its ramifications for the population in the Americas and spread of the virus worldwide. The Zika virus disease is a relatively new phenomenon for which sufficient and comprehensive data and investigative reports have not been available to date.